Traditional Chinese medicine composition for treating obesity and preparation method thereof
Through scientific combination of traditional Chinese medicine compositions prepared by Chinese herbal medicine, it provides treatment plans to nourish the spleen and kidneys, warm the yang and promote diuresis to target the individual differences in obesity and the side effects of Western medicine, achieving significant weight loss effects and safety, and solving existing obesity The individual differences and side effects of treatment methods have significantly improved the therapeutic effect and safety.
Patent Information
- Application Number
- CN202411425269.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-12
- Publication Date
- 2024-11-22
AI Technical Summary
The existing obesity treatment methods have not fully considered individual differences. There are side effects of long-term use of Western medicine, high surgical risks and limited treatment effects. Traditional Chinese medicine research has not yet formed an effective comprehensive therapeutic effect and safe preparation.
Develop a Chinese medicine composition, which is prepared into pills by scientifically combining a variety of Chinese herbal medicines, has the effects of nourishing the spleen and kidneys, warming the yang and promoting diuresis. It is used for central obesity, dyslipidemia and metabolic syndrome, etc. in spleen and kidney yang deficiency. Clinical verification and preparation process optimization to form safe and efficient Chinese medicine preparations.
This traditional Chinese medicine composition significantly improves Chinese medicine symptoms in clinical application, lose weight and lose weight, reduce fasting serum insulin, and has a total effective rate of 80% and 67% for patients with simple obesity and metabolic obesity, with no adverse reactions, and has long-term use of liver and kidneys without liver and kidney Damage has the advantages of safety and effectiveness.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention belongs to the field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition for treating obesity and a preparation method thereof. Background Art
[0002] The World Health Organization (WHO) defines overweight and obesity as abnormal or excessive fat accumulation that can impair health. With the development of society, overweight and obesity have not only become a serious public health problem, but their incidence has also been increasing year by year. Obesity is a modifiable risk for many diseases, especially visceral adipose tissue can regulate proinflammatory cytokines (such as interleukin-6), leading to inflammation, oxidative stress and insulin resistance, thereby increasing the risk of chronic diseases (Thomas DM, Brdau C, Bosy-Wesiphal A, et al. Relationships between bodyweight with body fat and visceral adipose tissue e-menging from a new geometrical model [J]. Obesity (Silver Spring), 2013, 21 (11): 2264-2271.). Over the past 40 years, the number of obese people has doubled, and it is estimated that by 2035, nearly one in two adults will suffer from obesity (John W Ostrominski, Tiffany M Powell-Wiley. Risk Stratification and Treatment of Obesity for Primany and Seconary Prevention of Candidiasis [J]. Cur Atherseler Rep, 2024, 26 (1): 11-23.). Obesity can pose a serious threat to human health and can also cause serious social and psychological diseases, causing great damage to people's bodies and putting great pressure on the world economy (Wu Chunqin, Ni Yingqun. Clinical experience in treating obesity based on spleen deficiency and dampness [J]. Journal of Clinical Chinese Medicine, 2024, 36 (07): 1244-1247.).
[0003] Obesity was recorded as early as in the Neijing, which systematically recorded the etiology, pathogenesis and symptoms of obesity and classified obesity. For example, the Suwen Tongping Xushi Lun describes "fat noble people". The Lingshu Weiqi Disorder says: "People are fat, fat, and meat. Those with firm popliteal flesh and full skin are fat. Those with loose popliteal flesh and loose skin are fat. Those with inseparable skin and flesh are meat." "Fat people have more qi and loose skin, so they can hang fat." It also says: "Fat people have less blood and less qi, so they cannot grow big." Here, people are divided into fat, fat, meat, fat and other body types, and it is pointed out that different body types have different clinical characteristics of obesity. In terms of etiology, Suwen Qibing Lun records "like to eat sweet and delicious food and eat a lot of fat"; Suwen Yifa Fangyi Lun also records "the people in the west eat Chinese food and are fat", indicating that the occurrence of obesity is related to multiple factors such as excessive consumption of fat and sweet food and geographical environment. In addition, Huangdi Neijing believes that obesity is related to many other diseases and symptoms, and recognizes that obesity can be transformed into thirst. Suwen·Qibinglun has the following chapter: "This is the origin of fatness. This person must eat sweet and fat frequently. Fat makes people feel hot inside, and sweet makes people feel full, so their qi overflows and turns into thirst." In addition, obesity is also related to many diseases such as fainting, hemiplegia, paralysis, and qi fullness. On this basis, later doctors have further understood the pathogenesis and treatment of obesity. Li Dongyuan pointed out the close connection between spleen and stomach function and obesity in "Spleen and Stomach Theory", believing that if the spleen and stomach are both strong, they can eat and become fat; if the spleen and stomach are weak, they can eat less and become fat. Zhu Zhenheng proposed in "Danxi Xinfa" that obesity has the characteristics of more dampness, more phlegm, and more qi on the outside and less on the inside, and believed that obesity should be treated from the two aspects of dampness and heat and qi deficiency. Liu Wansu's "Suwen Xuanji Yuanbingshi" believes that obese people have more blood and weak qi, and their pores are often stagnant, and it is difficult for qi and blood to flow freely, which may be accompanied by the characteristics of qi stagnation and blood stasis. Zhang Jiebin's "Jingyue Quanshu·Miscellaneous Symptoms·Non-wind" records that obese people often have weak qi and phlegm and dampness, which can easily lead to poor airway, so they are mostly non-wind symptoms. Chen Shiduo's "Shishi Milu·Fat Treatment Method" in the Qing Dynasty believes that "obese people have more phlegm, which is qi deficiency." Therefore, to treat phlegm, it is necessary to replenish qi and eliminate phlegm, and replenish vital fire, so that the qi is sufficient and the phlegm disappears. Wu Benli recorded in "Nu Ke Qie Yao": "Fat and white women, amenorrhea and obstruction must be caused by phlegm and dampness and fat membrane obstruction." Pointed out the connection between obesity and women's diseases. Combining the views of various schools, the causes of obesity are mostly related to innate endowment factors, improper diet, excessive consumption of fat and sweet foods, long-term sitting and little exercise, imbalance between work and rest, and emotional imbalance. The pathogenesis is mainly related to "spleen and kidney yang deficiency" and "qi deficiency", among which "phlegm and dampness" is the symptom and "spleen and kidney yang deficiency" and "qi deficiency" are the root causes.Western medicine believes that obesity is a chronic metabolic disease caused by excessive accumulation or uneven distribution of fat in the body, and closely links it with a variety of chronic diseases such as diabetes, hypertension, metabolic syndrome, cardiovascular and cerebrovascular diseases (Nutrition and Metabolic Management Branch of China Medical Health International Exchange Promotion Association, Clinical Nutrition Branch of Chinese Nutrition Society, Diabetes Branch of Chinese Medical Association, etc., China Overweight / Obesity Medical Nutrition Treatment Guidelines (2021) [J]. Chinese Journal of Medical Frontiers (Electronic Edition), 2021, 13(11): 1-55.), which poses a serious threat to human health and also increases social and economic pressures. Therefore, solving the problem of obesity is urgent.
[0004] At present, Western medicine has formed a relatively complete diet and exercise intervention program. Lifestyle intervention combining diet, exercise and behavioral intervention is the basic treatment plan for obesity, and can be combined with Western medicine and surgical treatment when necessary. However, its program is relatively general and does not fully consider individual differences, so patients often find it difficult to adhere to strict diet and exercise programs (Song Changmei, Gao Chunyang, Fu Yanlai, et al. Progress in TCM Research on Obesity [J]. Modern Chinese Medicine, 2021, 41(03): 6-9.). However, long-term use of Western medicine has obvious damage to the body and side effects, such as gastrointestinal dysfunction and severe rebound phenomenon. The risk of surgery is high and postoperative complications are frequent. In addition, oral weight loss drugs are absorbed through the digestive system, have a slow effect and are difficult to act directly on the lesions, resulting in limited therapeutic effects. With the deepening of research on traditional Chinese medicine, more and more Chinese herbal medicines have been found to have the potential to treat obesity. These Chinese herbal medicines work together to treat obesity through different mechanisms of action, such as regulating metabolism, lowering blood lipid and cholesterol levels, reducing appetite and fat intake, and increasing the oxidation of body fat. In addition, TCM treatment is based on the principle of syndrome differentiation and treatment, taking into full account the individual factors of the patient. Studies have combined treatments such as Chinese medicine or acupuncture with lifestyle intervention to form a comprehensive treatment method, which has achieved significant therapeutic effects. Studies have found that special therapies such as acupuncture, moxibustion, and acupoint thread embedding can regulate the body's endocrine system and improve metabolic function by stimulating specific acupoints, thereby achieving the purpose of reducing body weight and reducing abdominal fat accumulation (Li Ling, Yang Zhe, Ai Bingwei. Clinical research progress on acupuncture and special therapies for the treatment of abdominal obesity [J]. Journal of Practical Chinese Medicine Internal Medicine, 2024, 38(08): 7-11.). Therefore, it is particularly important to develop a Chinese medicine preparation with significant efficacy, safety and reliability and its preparation process. Summary of the invention
[0005] The present invention aims to provide a treatment plan of traditional Chinese medicine for obesity. The present invention scientifically combines and clinically verifies a variety of Chinese herbal medicines with the potential to treat obesity, and provides a Chinese medicine composition with good comprehensive efficacy and high safety. After long-term clinical and systematic verification, the prescription has the effects of tonifying the spleen and kidney, warming yang and promoting diuresis. It is used for central obesity of spleen and kidney yang deficiency type, dyslipidemia, metabolic syndrome, etc., and has a significant effect on obesity, puffy swelling, fear of cold, fatigue, laziness, heavy body, hyperhidrosis, sore waist and weak legs, abdominal distension, poor appetite and loose stools. Based on this, the present invention is completed.
[0006] In a first aspect, the present invention provides a traditional Chinese medicine composition, wherein the traditional Chinese medicine composition is made of the following traditional Chinese medicines in parts by weight:
[0007] The main drug is 60-110 parts of processed aconite root;
[0008] The ministerial drugs include 180-230 parts of Astragalus and 80-130 parts of Poria;
[0009] The adjuvants include 60-110 parts of dried tangerine peel, 60-110 parts of red yeast rice, 180-230 parts of wax gourd peel, 40-90 parts of oriental rhizome, 40-90 parts of lotus leaf, 40-90 parts of duckweed, 40-90 parts of turmeric, 180-230 parts of raw hawthorn, 180-230 parts of gynostemma pentaphyllum, 60-110 parts of northern bupleurum, 40-90 parts of stir-fried mustard seeds and 60-110 parts of cimicifuga;
[0010] The adjuvant is 40-90 portions of liquorice tablets.
[0011] Furthermore, the Chinese medicine composition is made of the following Chinese medicines in parts by weight:
[0012] The main drug is 70-100 parts of processed aconite root;
[0013] The ministerial drugs include 190-220 parts of Astragalus and 90-120 parts of Poria;
[0014] The adjuvants include 70-100 parts of dried tangerine peel, 70-100 parts of red yeast rice, 190-220 parts of wax gourd peel, 50-80 parts of oriental rhizome, 50-80 parts of lotus leaf, 50-80 parts of duckweed, 50-80 parts of turmeric, 190-220 parts of raw hawthorn, 190-220 parts of gynostemma pentaphyllum, 70-100 parts of northern bupleurum, 50-80 parts of stir-fried mustard seeds and 70-100 parts of cimicifuga;
[0015] The drug is 50-80 portions of licorice tablets.
[0016] Furthermore, the Chinese medicine composition is made of the following Chinese medicines in parts by weight:
[0017] The main drug is 80-90 parts of processed aconite root;
[0018] The ministerial drugs include 200-210 parts of Astragalus and 100-110 parts of Poria;
[0019] The adjuvants include 80-90 parts of dried tangerine peel, 80-90 parts of red yeast rice, 200-210 parts of wax gourd peel, 60-70 parts of oriental rhizome, 60-70 parts of lotus leaf, 60-70 parts of duckweed, 60-70 parts of turmeric, 200-210 parts of raw hawthorn, 200-210 parts of gynostemma pentaphyllum, 80-90 parts of northern bupleurum, 60-70 parts of stir-fried mustard seeds and 80-90 parts of cimicifuga;
[0020] The adjuvant is 60-70 portions of licorice tablets.
[0021] In a second aspect, the present invention provides a traditional Chinese medicine preparation, which is prepared from the traditional Chinese medicine composition described in the first aspect.
[0022] Furthermore, the Chinese medicine preparation also contains pharmaceutically acceptable excipients required for the corresponding preparation.
[0023] Furthermore, the excipient is a pharmaceutical excipient that enhances the efficacy, reduces toxicity and / or alleviates side effects of the main drug.
[0024] Furthermore, the Chinese medicine preparation is one or more of paste prescriptions, pills, pills, decoctions, granules, capsules, powders and / or tablets.
[0025] Preferably, the Chinese medicine preparation is a pill.
[0026] In a third aspect, the present invention provides a method for preparing a Chinese medicine preparation, wherein the Chinese medicine preparation is composed, by weight, of 60-110 parts of processed aconite, 180-230 parts of astragalus, 80-130 parts of poria, 60-110 parts of tangerine peel, 60-110 parts of red yeast rice, 180-230 parts of wax gourd peel, 40-90 parts of oriental arisaema, 40-90 parts of lotus leaf, 40-90 parts of duckweed, 40-90 parts of turmeric, 180-230 parts of raw hawthorn, 180-230 parts of gynostemma pentaphyllum, 60-110 parts of northern bupleurum, 40-90 parts of stir-fried mustard seeds, 60-110 parts of cimicifuga and 40-90 parts of liquorice tablets, and the preparation steps are as follows:
[0027] S1. Preparation of Chinese medicine powder: Mix and grind raw hawthorn, Gynostemma pentaphyllum, tangerine peel, red yeast rice, oriental rhizome, turmeric, Poria cocos, northern bupleurum, and cimicifuga into fine powder;
[0028] S2. Preparation of Chinese medicine thick paste: boil wax gourd peel, lotus leaf, duckweed, processed aconite, astragalus, fried mustard, licorice tablets, filter, combine the filtrate, dry, and concentrate into a thick paste;
[0029] S3. The fine powder of traditional Chinese medicine prepared in S1 is mixed with the thick paste of traditional Chinese medicine prepared in S2 to make a soft material;
[0030] S4. The soft material prepared in S3 is placed in a pill making machine to be made into pellets of prescribed requirements, thereby obtaining the pills of the Chinese medicine preparation of the present invention.
[0031] Furthermore, in step S2, the decoction is performed 1-3 times.
[0032] Preferably, the decoction is performed twice.
[0033] Furthermore, in step S2, the amount of water added is 9 to 11 times the weight of the medicinal materials.
[0034] Furthermore, the amount of water added is 10 times the weight of the medicinal materials for the first time, and 9 times the weight of the medicinal materials for the second time.
[0035] Furthermore, in step S2, each decoction time is 0.5-1.5h.
[0036] Preferably, the decoction time for each time is 1.5 hours for the first decoction and 0.5 hours for the second decoction.
[0037] Furthermore, in step S2, the drying method is reduced pressure concentration.
[0038] Furthermore, the vacuum degree is -0.06 to -0.12, and the concentration temperature is 55 to 65°C.
[0039] In a fourth aspect, the present invention provides use of the Chinese medicine composition described in the first aspect or the Chinese medicine preparation described in the second aspect in the preparation of a drug for treating obesity.
[0040] Furthermore, the obesity includes simple obesity and metabolic obesity.
[0041] The medicinal properties and effects of each Chinese medicinal material in the present invention are as follows:
[0042] Raw hawthorn: sour, sweet, slightly warm. Enters the spleen, stomach, and liver meridians. Has the effects of digesting food and strengthening the stomach, promoting qi and dispersing blood stasis, removing turbidity and reducing fat. Used for meat stagnation, stomach distension, diarrhea and abdominal pain, blood stasis and amenorrhea, postpartum blood stasis, heart and abdomen stabbing pain, chest pain, hernia pain, and hyperlipidemia. Scorched hawthorn has a stronger effect of digesting food and removing stagnation. Used for meat stagnation and diarrhea.
[0043] Gynostemma pentaphyllum: bitter, slightly sweet, cool in nature. Enters the lung, spleen, and kidney meridians. Has the effects of clearing away heat and detoxifying, and replenishing deficiency. Main body weakness, asthenia, loss of spermatorrhea, leukopenia, hyperlipidemia, viral hepatitis, chronic gastroenteritis, chronic tracheitis.
[0044] Tangerine peel: bitter, pungent, warm in nature. Enters the lung and spleen meridians. Has the effects of regulating qi and strengthening the spleen, drying dampness and resolving phlegm. Used for abdominal distension, loss of appetite, vomiting and diarrhea, and cough with excessive phlegm.
[0045] Red yeast rice: sweet, warm, non-toxic. Enters the liver, spleen, stomach, and large intestine meridians. Has the effects of promoting blood circulation and removing blood stasis, strengthening the spleen and promoting digestion. Treats postpartum lochia, abdominal pain due to blood stasis, fullness due to food accumulation, red and white diarrhea, and traumatic injuries.
[0046] Winter melon peel: sweet in taste, cool in nature. Enters the spleen and small intestine meridians. Has diuretic and swelling-reducing effects. Used for edema, urination difficulties, summer heat and thirst, and short and dark urine.
[0047] Alisma: Sweet, light, cold in nature. Enters the kidney and bladder meridians. Has the effects of promoting diuresis and dispelling dampness, purging heat, clearing turbidity and reducing lipids. Used for urinary problems, edema, diarrhea, oliguria, phlegm and dizziness, hot stranguria, and hyperlipidemia.
[0048] Lotus leaf: bitter, neutral in nature. Enters the liver, spleen, and stomach meridians. Has the effects of clearing away heat and dampness, promoting the clear yang, cooling blood and stopping bleeding. Used for summer heat and thirst, summer dampness diarrhea, spleen deficiency diarrhea, blood heat and vomiting and bleeding, and metrorrhagia. Lotus leaf charcoal astringes, removes blood stasis and stops bleeding. Used for hemorrhage and postpartum blood fainting.
[0049] Duckweed: spicy, cold in nature. Enters the lung meridian. Has the effects of dispersing wind-heat, clearing rashes, and promoting diuresis. Used for measles that do not clear up, urticaria itching, edema and oliguria.
[0050] Processed Aconite (Heishun Tablet): Spicy, sweet, hot, toxic. Enters the heart, kidney, and spleen meridians. Has the effects of restoring yang and rescuing adverse conditions, replenishing fire and supporting yang, dispersing and relieving pain. Used for yang deficiency and collapse, cold limbs and weak pulse, insufficient heart yang, chest pain, vomiting and diarrhea due to deficiency and cold, cold pain in the abdomen, kidney yang deficiency, impotence and cold uterus, edema due to yin cold, external infection due to yang deficiency, and pain due to cold and dampness.
[0051] Astragalus: sweet, slightly warm. Enters the lung and spleen meridians. It has the effects of replenishing qi and raising yang, consolidating the exterior and stopping sweating, promoting diuresis and reducing swelling, promoting fluid and nourishing blood, relieving stagnation and relieving arthritis, expelling toxins and expelling pus, and healing sores and promoting tissue regeneration. It is used for qi deficiency and fatigue, poor appetite and loose stools, sinking of qi in the middle, chronic diarrhea and prolapse of the anus, bloody stool and metrorrhagia, spontaneous sweating due to exterior deficiency, edema due to qi deficiency, internal heat and thirst, sallow complexion due to blood deficiency, hemiplegia, pain and numbness in the arthritis, and carbuncle that is difficult to heal and that does not heal for a long time.
[0052] Turmeric: pungent, bitter, warm in nature. Enters the spleen and liver meridians. Has the effects of breaking blood and promoting qi, dredges the menstrual passages and relieves pain. Used for chest and flank pain, chest obstruction and heart pain, dysmenorrhea, amenorrhea, masses, rheumatic shoulder and arm pain, and swelling and pain caused by falls.
[0053] Poria: sweet, light, neutral in nature. Enters the heart, lung, spleen, and kidney meridians. Has the effects of promoting diuresis and removing dampness, strengthening the spleen, and calming the mind. Used for edema, oliguria, phlegm and fluid, palpitations, spleen deficiency, poor appetite, loose stools, restlessness, palpitations, and insomnia.
[0054] Bupleurum chinense: Spicy and bitter, slightly cold in nature. Enters the liver, gallbladder, and lung meridians. Has the effects of dispersing fever, relieving liver depression, and raising Yang Qi. Used for colds and fever, alternating cold and heat, chest and flank pain, irregular menstruation, uterine prolapse, and rectal prolapse.
[0055] Stir-fried mustard seeds: spicy, warm in nature. Enters the lung meridian. Has the effects of warming the lungs, dispelling phlegm and promoting qi, dispersing stagnation and dredging collaterals to relieve pain. Used for cough caused by cold phlegm, chest and flank pain, phlegm stagnation in the meridians, numbness and pain in the joints, phlegm and dampness in the flow, and swelling and poison in the yin.
[0056] Cimicifuga: Spicy, slightly sweet, slightly cold. Enters the lung, spleen, stomach, and large intestine meridians. Has the effects of relieving rashes, clearing away heat and detoxifying, and raising Yang Qi. Used for wind-heat headache, toothache, mouth sores, sore throat, measles that do not break out, Yang poison spots, rectal prolapse, and uterine prolapse.
[0057] Licorice: sweet, neutral in nature. It enters the heart, lung, spleen, and stomach meridians. It has the effects of tonifying the spleen and replenishing qi, clearing away heat and detoxifying, removing phlegm and relieving cough, relieving pain, and harmonizing various medicines. It is used for spleen and stomach weakness, fatigue, palpitations and shortness of breath, cough with sputum, abdominal and limb cramps and pain, carbuncle, sore and ulcer, and relieves drug toxicity and potency.
[0058] The treatment principle of the present invention is:
[0059] The Chinese medicine composition of the present invention uses aconite as the main drug, which has a pungent and sweet taste, a hot nature, and enters the heart, spleen, and kidney meridians. It is free-flowing and can pass through the twelve meridians, so it can be used for all symptoms of insufficient yang qi, especially for replenishing kidney yang, removing the coldness of the internal organs; supplementing the insufficient yang qi, and warming the spleen and stomach. Astragalus and Poria are combined as the ministerial drugs. Astragalus is sweet and warm in nature, enters the spleen and lung meridians, and is the best tonic, which can have the effects of replenishing qi, consolidating the exterior, and promoting diuresis and reducing swelling. Poria, which has a sweet and light taste, a flat nature, enters the heart, lung, spleen, and kidney meridians, can promote diuresis and reduce swelling, and penetrate dampness and strengthen the spleen. With tangerine peel, it has a pungent and bitter taste, a warm nature, enters the spleen, stomach, and lung meridians, and has the effects of regulating qi and strengthening the spleen, regulating the middle and removing dampness. Red yeast rice is used as an adjuvant to help digestion, invigorate the spleen, replenish qi, and warm the middle. Winter melon peel, oriental rhizome, lotus leaf, duckweed and other medicines are used as adjuvants to promote diuresis, eliminate dampness and reduce swelling. Turmeric is used as an adjuvant, which is warm in nature and can be used with aconite to warm the spleen and stomach yang. Clean hawthorn is used as an adjuvant, which is sour and sweet, slightly warm in nature, and belongs to the spleen, stomach and liver meridians. It has the effects of digesting food and removing accumulation, promoting blood circulation and dispersing blood stasis. Qi and blood flow together, removing blood stasis without hurting new blood, and promoting stagnant qi without hurting the positive energy. It is used for symptoms such as meat stagnation. Gynostemma pentaphyllum is used as an adjuvant, which is bitter, slightly sweet, and cool in nature; it belongs to the lung, spleen, and kidney meridians to replenish qi and strengthen the spleen; Cimicifuga heracleifolia is spicy, slightly sweet, and slightly cold, and belongs to the lung, spleen, stomach, and large intestine meridians, and has the effect of raising yang; stir-fried mustard seeds are spicy, warm in nature, and belong to the lung meridian to warm and transform phlegm and dampness; Bupleurum chinense is spicy, bitter, and slightly cold in nature. It enters the liver, gallbladder, and lung meridians to raise Yang Qi, soothe the liver, regulate Qi, and relieve depression. When the liver is depressed and Qi is stagnant, the body fluids cannot flow smoothly, and when Qi is stagnant, the water is stagnant, Qi transformation is disordered, and phlegm and dampness are generated internally. It is supplemented with mustard and bupleurum to take advantage of their functions of soothing the liver, regulating Qi, and warming and transforming phlegm and dampness. Licorice is used to harmonize the various drugs and alleviate the toxicity of aconite. The combination of various drugs can regulate the five elements and coordinate the five flavors, achieving the effects of nourishing the spleen and kidney, warming Yang and promoting water excretion, treating both the symptoms and the root causes. It is indeed a good prescription for treating diseases such as central obesity, dyslipidemia, and metabolic syndrome of spleen and kidney Yang deficiency type.
[0060] Beneficial Effects
[0061] 1. The Chinese medicine formula of the present invention is an effective prescription for treating obesity developed under the guidance of traditional Chinese medicine theory and combined with clinical experience. The Chinese medicine is a compound preparation composed of more than 16 kinds of Chinese medicines, which has the effects of tonifying the spleen and kidney, warming yang and promoting diuresis. It is used for central obesity, dyslipidemia, metabolic syndrome, etc. of spleen and kidney yang deficiency type. In the past 5 years of clinical application, thousands of patients have been treated with good efficacy. It is well received by patients with central obesity, dyslipidemia, metabolic syndrome, etc., no adverse reactions occur, and no liver and kidney damage is observed after long-term use (more than 3 months). It is a safe and effective Chinese medicine prescription.
[0062] 2. The preparation process of the Chinese medicine preparation of the present invention is scientific and reasonable. The pills prepared by the preparation process have uniformity, good solubility and stability, and the operation method of the preparation process is simple and convenient, and has broad prospects for industrial application.
[0063] 3. Clinically verified, the Chinese medicine formula of the present invention can improve TCM symptoms, reduce weight, and reduce fasting serum insulin. The total effective rate for obese patients without insulin resistance is as high as 80%, and the total effective rate for obese patients with insulin resistance is 67%. The Chinese medicine preparation of the present invention has the advantages of significant clinical efficacy and safe medication in the treatment of obesity, and is worthy of promotion and application in clinical practice. DETAILED DESCRIPTION
[0064] The specific embodiments of the present invention are further described below. It should be noted that the description of these embodiments is used to help understand the present invention, but does not constitute a limitation of the present invention. In addition, the technical features involved in the embodiments described below can be combined with each other as long as they do not conflict with each other.
[0065] The experimental methods in the following examples are conventional methods unless otherwise specified, and the experimental materials used in the following examples are commercially available unless otherwise specified.
[0066] Explanation of terms
[0067] Simple obesity: refers to a type of obesity in which the body weight exceeds the normal range and there is no obvious pathological factor. It is mainly due to non-organic weight gain caused by excess energy, which is usually closely related to multiple factors such as genetics, environment, personal diet and exercise choices.
[0068] Metabolic obesity: a type of obesity caused by multiple factors. Its main feature is that the basal metabolic rate is abnormally reduced due to endocrine dysfunction, physical dysfunction or chronic inflammation, which in turn causes fat accumulation and weight gain.
[0069] Metabolic syndrome: (MS) refers to a pathological state in which the body's carbohydrates, fats, proteins and other substances are metabolically disturbed. Its four core characteristics are insulin resistance, visceral obesity, atherosclerotic dyslipidemia and endothelial dysfunction.
[0070] Example 1 Preparation method of Chinese medicine composition
[0071] 1.1 Research on extraction and preparation technology of traditional Chinese medicine preparations
[0072] 1.1.1 Treatment of fine powder odor
[0073] Take the best prescription dosage ratio of the present invention: 210 parts of raw hawthorn, 210 parts of gynostemma pentaphyllum, 84 parts of tangerine peel, 84 parts of red yeast rice, 70 parts of oriental rhizome, 70 parts of turmeric, 105 parts of poria, 84 parts of bupleurum, and 84 parts of cimicifuga are mixed and crushed into fine powder (passed through a 100-mesh sieve), repeated 3 groups, and the powder yield was calculated.
[0074] Table 1 Flour yield results
[0075] Test No. Before crushing (kg) After crushing (kg) Flour yield (%) 1 15.98 15.66 98 2 15.98 15.34 96 3 15.98 15.50 97
[0076] 1.1.2 Treatment of dry plaster smell
[0077] The best prescription dosage ratio of the present invention is taken as follows: 210 parts of wax gourd peel, 70 parts of lotus leaves, 70 parts of duckweed, 84 parts of processed aconite (Heishun tablets), 210 parts of astragalus, 70 parts of fried mustard seeds, and 70 parts of liquorice tablets are added with water in an amount of 9 to 11 times the weight of the medicinal materials, and the water is decocted 1 to 3 times, each decoction time is 0.5 to 1.5 hours, filtered, the filtrate is combined, and the filtrate is concentrated and dried under reduced pressure, wherein the vacuum degree is -0.06 to -0.12, the concentration temperature is 55 to 65°C, the volume is fixed to a 500mL volumetric flask, and 20mL is accurately drawn and placed at 105°C for drying for 3 hours, and then placed in a beaker to be cooled, evaporated to dryness in a water bath, dried at 105°C for 2.5 hours, placed in a desiccator to cool, weighed, and the dry paste yield is calculated.
[0078] The method for determining the dry paste in the Chinese medicine extract of the present invention is as follows: the method for calculating the yield of the dry paste extracted of the present invention: Dry paste yield (%) = dry paste solid amount in the extract / amount of input medicinal materials × 100%.
[0079] The experiment was repeated for 9 groups. The dosage ratio, operation method and content detection method of the Chinese medicinal materials were the same in each group, but the amount of water added and the decoction time were different. The specific operations and results are shown in Table 2.
[0080] Table 2 Optimization test of the process parameters for extracting and preparing Chinese medicine of the present invention
[0081]
[0082]
[0083] From the results in Table 2, it can be seen that in terms of the dry paste yield of the Chinese medicine preparation of the present invention, although the dry paste yield of the Chinese medicine extraction of the present invention is relatively high for the addition of 11 times the amount of water, for the subsequent extraction and concentration of the Chinese medicine preparation, appropriately reducing the amount of water added is conducive to reducing the amount and time of concentration. In summary, in order to achieve the best extraction efficiency, the preferred optimal process of the present invention is that the present invention adds 10 times the weight of the medicinal material water for the first time, and the decoction time is 1.5 hours, and the present invention adds 9 times the amount of water for the second time, and the decoction time is 0.5 hours.
[0084] 1.2 Research on the molding preparation process of the present invention
[0085] 1.2.1 Study on the preparation process parameters of traditional Chinese medicine preparations
[0086] Mix and grind raw hawthorn, gynostemma pentaphyllum, tangerine peel, red yeast rice, oriental rhizome, turmeric, tuckahoe, northern bupleurum and cimicifuga into fine powder (pass through a 100-mesh sieve), add 9-11 times the weight of water to wax gourd peel, lotus leaf, duckweed, processed aconite (Heishun tablets), astragalus, stir-fried mustard seeds and liquorice tablets, boil 1-3 times with water, each boiling time is 0.5-1.5h, filter, combine the filtrates, concentrate and dry under reduced pressure, wherein the vacuum degree is -0.06--0.12, the concentration temperature is 55-65°C, concentrate into a thick paste, add fine powder, mix evenly, dry, add water and mix evenly to make a soft material, put the soft material into a pill making machine to make pills of specified requirements, dry (each 10 pills weigh 1.5g), and make 1000g in total to obtain the pills of the Chinese medicine preparation of the present invention.
[0087] 1.2.2 Prescription quantity of preparation
[0088] 210 parts of raw hawthorn, 210 parts of gynostemma pentaphyllum, 84 parts of dried tangerine peel, 84 parts of red yeast rice, 210 parts of wax gourd peel, 70 parts of rhizoma alismatis, 70 parts of lotus leaves, 70 parts of duckweed, 84 parts of processed aconite (Heishun tablets), 210 parts of astragalus, 70 parts of turmeric, 105 parts of poria, 84 parts of northern bupleurum, 70 parts of stir-fried mustard seeds, 84 parts of cimicifuga, and 70 parts of liquorice tablets.
[0089] 1.2.3 Determination of dosage, filling quantity and specifications
[0090] (1) Dosage and Administration: Oral administration. 6g each time, 3 times a day. Or as directed by a doctor.
[0091] (2) Packaging specifications: 60g / bottle / box.
[0092] 1.2.4 Investigation on the quality stability of the pills of the present invention
[0093] Three batches of pills were prepared according to the preparation method described in 1.2.1 and quality evaluation was performed, that is, the properties, solubility, content and other items of the Chinese medicine pills of the present invention were examined through a 12-month long-term stability test.
[0094] Table 3 Test of pills of the present invention
[0095]
[0096] From the experimental results in Table 3, it can be seen that the solubility of the pills of the present invention meets the requirements of the pharmacopoeia, and the technological production meets the production standard requirements.
[0097] After 12 months, the appearance, properties and content of the pills did not change, and no moisture absorption was found, which also shows that the pills of the present invention have good stability.
[0098] 1.3 Research Conclusions
[0099] The preparation process of the preparation of the invention is scientific and reasonable. The pills prepared by the preparation process have uniformity, good solubility and stability. The operation method of the preparation process is simple and stable, and has broad industrial application prospects.
[0100] Example 2 Clinical Study
[0101] 2.1 Research Methods
[0102] 300 patients (outpatients from the Department of Endocrinology 1 from May 2023 to August 2024) were selected, and the clinical efficacy after 1 to 2 courses of treatment was statistically analyzed.
[0103] 2.2 Case Source
[0104] Outpatient patient of Department of Endocrinology 1 from May 2023 to August 2024.
[0105] 2.3 Diagnostic criteria
[0106] 2.3.1 Western medicine diagnostic criteria
[0107] According to the definition of body mass index (BMI), the BMI ranges from 24.0 to 27.9 kg / m2, which was proposed in the Health Industry Standard of the People's Republic of China: Determination of Adult Weight (WS / T428-2013) issued in 2013 and the Expert Consensus on Prevention and Treatment of Adult Obesity in China issued by the Obesity Group of the Endocrinology Branch of the Chinese Medical Association in 2011. 2 Overweight, BMI ≥ 28.0 kg / m 2 For obesity.
[0108] 2.3.2 TCM diagnostic criteria
[0109] The diagnostic criteria for spleen and kidney yang deficiency syndrome were formulated based on the TCM syndrome differentiation criteria (referring to the Expert Consensus on TCM Diagnosis and Treatment of Obesity (Journal of Beijing University of Chinese Medicine) and the TCM Comprehensive Diagnosis and Treatment Ideas and Methods for Simple Obesity (Journal of Practical TCM Internal Medicine), combined with our department's many years of clinical practice), as follows:
[0110] Main symptoms: obesity, puffy swelling, fear of cold, fatigue, sore waist and weak legs, abdominal distension and fullness, poor appetite, loose stools, pale tongue, thin white fur, and deep, thready and weak pulse.
[0111] Secondary symptoms: like to drink warm water, cold in the navel, fatigue and laziness, heavy body, sweating, cold body due to sweating, and clear and long urination.
[0112] To diagnose this syndrome, two main symptoms, one secondary symptom, and reference to the tongue and pulse are required.
[0113] 2.4 Inclusion and Exclusion Criteria
[0114] 2.4.1 Inclusion criteria
[0115] (1) Patients who meet the following Western medical diagnostic criteria and TCM differentiation of spleen and kidney yang deficiency syndrome;
[0116] (2) The patient's body mass index (BMI) is between 24-27.9 kg / m 2 (overweight), or between 28-31.9kg / m 2 ;
[0117] (3) The patient's body mass index (BMI) is between 24-27.9 kg / m 2 (overweight), or between 28-31.9kg / m 2 , and the insulin resistance index is greater than 2.69;
[0118] (4) Those aged between 18 and 65, regardless of gender, with clear consciousness and no obvious impairments.
[0119] Only one of (2) or (3) is required.
[0120] 2.4.2 Exclusion criteria
[0121] (1) Patients whose syndrome differentiation is unclear or do not belong to the above syndrome types;
[0122] (2) Pregnant or lactating women;
[0123] (3) Patients with severe primary diseases of the cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems, as well as mental illness;
[0124] (4) Those with allergic constitution or multiple drug allergies;
[0125] (5) Obesity caused by certain endocrine diseases (adrenocortical hypofunction, Cushing's disease, etc.) or obesity caused by illness or taking certain drugs;
[0126] (6) Those who have undergone weight loss surgery within the past year or whose BMI value has reached the surgical indication ≥32 kg / m 2 .
[0127] 2.5 Falling off and rejection criteria
[0128] 2.5.1 Case exclusion and dropout
[0129] (1) If a case is found not to meet the inclusion criteria after inclusion, it must be excluded;
[0130] (2) Subjects with poor compliance, serious adverse events, and other reasons that make them unsuitable to continue the trial, or those who withdraw on their own initiative are all considered dropouts.
[0131] 2.5.2 Treatment of dropout cases
[0132] When a subject drops out, the researcher should take active measures to complete the last test as much as possible in order to analyze its efficacy and safety. For all dropout cases, the trial conclusion form and the reason for the dropout should be filled in the case report form.
[0133] 2.6 Treatment methods
[0134] The prescription of the present invention comprises 210 parts of raw hawthorn, 210 parts of gynostemma pentaphyllum, 84 parts of dried tangerine peel, 84 parts of red yeast rice, 210 parts of wax gourd peel, 70 parts of oriental rhizome, 70 parts of lotus leaf, 70 parts of duckweed, 84 parts of processed aconite (Heishun tablets), 210 parts of astragalus, 70 parts of turmeric, 105 parts of poria, 84 parts of northern bupleurum, 70 parts of stir-fried mustard seeds, 84 parts of cimicifuga and 70 parts of liquorice tablets.
[0135] Usage: Oral decoction, 200ml at a time, twice a day.
[0136] Treatment course: 1 course, one course per month.
[0137] 2.7 Observation indicators
[0138] Main efficacy indicator: Body mass index (BMI).
[0139] Secondary efficacy indicators: fasting blood glucose (FPG), fasting serum insulin (FINS), insulin resistance index (HOMA-IR) and TCM syndrome efficacy evaluation after one course of treatment.
[0140] 2.8 Evaluation of efficacy
[0141] Markedly effective: ① After one course of medication, compared with the initial fasting weight, the weight decreased significantly, with a large decrease (more than 2.0KG), and the symptoms (including puffiness and swelling, chills, fatigue, lethargy, heaviness, sweating, back pain and weak legs, abdominal distension, poor appetite, loose stools, etc.) were significantly improved; ② Fasting blood glucose (FPG), fasting serum insulin (FINS), and insulin resistance index (HOMA-IR) were lower than before.
[0142] Effective: After one course of medication, compared with the initial fasting weight, the weight decreased, but the magnitude or speed was small, and the symptoms were partially improved or slightly improved. ② Fasting serum insulin (FINS) and insulin resistance index (HOMA-IR) did not decrease significantly, but the symptoms were partially improved or slightly improved.
[0143] Ineffectiveness: After one course of medication, compared with the initial fasting weight, there is no significant change in body weight or it continues to increase, and there is no improvement in symptoms.
[0144] 2.9 Research Results
[0145] Among the 300 patients collected, there were 194 patients with metabolic obesity and 106 patients with simple obesity. The changes in the main and secondary efficacy indicators of the patients before and after treatment are shown in Table 1-2, and the efficacy evaluation of the patients after treatment is shown in Table 3.
[0146] Among patients with simple obesity: markedly effective: 74 cases (38.6%); effective: 84 cases (43.3%); ineffective: 22 cases (11.3%); the total effective rate was 80%.
[0147] Among patients with metabolic obesity: marked effect: 30 cases (28.3%), effective: 41 cases (38, 7%), ineffective: 10 cases (9.6%); the total effective rate was 67%.
[0148] Table 1 Changes in the main efficacy indicators of patients before and after treatment
[0149]
[0150] Table 2 Changes in secondary efficacy indicators of patients before and after treatment
[0151]
[0152]
[0153] Table 3 Evaluation of the efficacy of patients after treatment
[0154] Group n Significantly effective cases (%) Effective cases (%) Ineffective cases (%) Total effective (%) Simple obesity 194 74(38.6%) 84(43.3%) 22(11.3%) 80% Metabolic obesity 106 30(28.3%) 41(38.7%) 10(9.6%) 67%
[0155] 2.10 Research Conclusions
[0156] The Chinese medicine prescription of the present invention can improve TCM symptoms, reduce weight, and reduce fasting serum insulin. The total effective rate for simple obesity patients is as high as 80%, and the total effective rate for metabolic obesity patients is 67%. In addition, the Chinese medicine prescription has no adverse reactions during the treatment period, and no liver and kidney damage is observed after long-term use (more than 3 months). It is a safe and effective Chinese medicine prescription. The Chinese medicine preparation of the present invention has the advantages of significant clinical efficacy and safe medication in treating obesity, and is worthy of promotion and application in clinical practice.
[0157] Typical clinical case 1
[0158] Gender: Female Age: 39
[0159] First visit date: June 29, 2023
[0160] Chief complaint: Obesity for 1 year
[0161] History of present illness:
[0162] Obese, wants to lose weight, gained 35kg in 1 year, poor diet, bowel movements 3 times a day, difficulty falling asleep, light sleep, easy awakening, and difficulty falling asleep after waking up.
[0163] Epidemiological survey:
[0164] No fever, cough, fatigue, etc. in the recent period.
[0165] Past medical history and other medical history: None
[0166] Inspection, auscultation and palpation:
[0167] The tongue is pale red, the tongue coating is thin white, and the pulse is stringy.
[0168] Physical examination:
[0169] Height 158cm, weight 110kg, BMI: 44.06kg / m 2 .
[0170] Auxiliary examination:
[0171] Serum insulin: 16.9 μU / mL.
[0172] Initial diagnosis:
[0173] TCM diagnosis (TCM syndrome): Obesity (phlegm-dampness syndrome)
[0174] Disposal suggestions:
[0175] 12 packs: 12g dried tangerine peel, 12g aconite root, decocted first, 15g poria, 10g licorice slices, 10g lotus leaf, 10g oriental rhizome, 30g wax gourd peel, 10g duckweed, 10g turmeric, 30g astragalus, 12g red yeast rice, 30g clean hawthorn, and 12g cimicifuga.
[0176] One dose / day, divided into two doses / day, 200ml each time, decocted in 400ml water.
[0177] Follow-up date: October 30, 2023
[0178] Epidemiological survey:
[0179] No fever, cough, fatigue, etc. in the recent period.
[0180] symptom:
[0181] Poor night sleep improved and menstruation returned to normal; the rest did not complain of obvious discomfort.
[0182] Previous medical history of "hyperlipidemia"; take fenofibrate capsules orally, 1 tablet each morning and evening.
[0183] Inspection, auscultation and palpation:
[0184] Pale tongue, thin white fur, deep pulse
[0185] Physical examination:
[0186] 95.7kg, weight loss of 0.75kg in the past 2 weeks, BMI: 38.34kg / m 2 .
[0187] Auxiliary examination:
[0188] Serum insulin: 10.6 μU / mL.
[0189] diagnosis:
[0190] TCM diagnosis (TCM syndrome type): 1. Obesity (phlegm-dampness syndrome); 2. Diagnosis of blood turbidity and blood stasis.
[0191] Western medicine diagnosis: 1. Hyperlipidemia; 2. Insulin resistance.
[0192] Treatment advice:
[0193] 12 packs: 12g of dried tangerine peel, 12g of aconite root, 15g of poria, 10g of licorice slices, 10g of lotus leaf, 10g of oriental water plantain, 30g of wax gourd peel, 10g of duckweed, 10g of turmeric, 30g of astragalus, 12g of red yeast rice, 30g of clean hawthorn, 12g of cimicifuga, 30g of gynostemma pentaphyllum, and 30g of pumice, decocted first.
[0194] One dose per day, divided into two doses per day, 200ml each time, decocted in 400ml water.
[0195] Treatment Effect:
[0196] After one course of medication, compared with the initial diagnosis, TCM symptoms improved, weight decreased, and fasting serum insulin decreased.
[0197] Typical clinical case 2
[0198] Gender: Female Age: 43
[0199] First visit date: May 22, 2023
[0200] Chief complaint: fatigue for more than 3 months
[0201] History of present illness:
[0202] Presently he has fatigue, excessive sweating, unformed stools, 2-5 times / day, normal appetite and sleep, and regular urination.
[0203] Each menstruation is 3-7 days earlier than the previous one, 1mp: 2023.05.05, the quantity, color and quality are normal.
[0204] Epidemiological survey:
[0205] No fever, cough, fatigue, etc. in the recent period.
[0206] Past medical history and other medical history: denied.
[0207] Inspection, auscultation and palpation:
[0208] The tongue is pale and dark with white coating, teeth marks on the edges, and the pulse is deep.
[0209] Physical examination:
[0210] Height: 1.63m, Weight: 95kg, BMI: 35.76kg / m 2 .
[0211] Auxiliary examination:
[0212] Fasting insulin: 26 μU / mL.
[0213] diagnosis:
[0214] TCM diagnosis (TCM syndrome): Obesity (phlegm-dampness syndrome)
[0215] Disposal suggestions:
[0216] 6 packs: 12g dried tangerine peel, 12g aconite root, decocted first, 15g poria, 10g licorice slices, 10g lotus leaf, 10g oriental rhizome, 30g wax gourd peel, 10g duckweed, 10g turmeric, 30g astragalus, 12g red yeast rice, 15g stir-fried cassia seed, 30g gynostemma pentaphyllum, and 30g clean hawthorn.
[0217] One dose / day, divided into two doses / day, 200ml each time.
[0218] Follow-up date: August 14, 2023
[0219] Epidemiological survey:
[0220] No fever, cough, fatigue, etc. in the recent period.
[0221] Current symptoms:
[0222] Excessive sweating, aggravated by movement, bowel movements 2-3 times / day, normal appetite and sleep, regular urination. Menstruation is 7 days earlier than before, 1mp: 2023.07.27, normal quantity, color and quality. Normal appetite, normal sleep at night.
[0223] Inspection, auscultation and palpation:
[0224] The tongue is red, with tooth marks, white tongue coating, and the pulse is deep and fine.
[0225] Physical examination:
[0226] 85.7kg, BMI: 32.26kg / m 2 .
[0227] Auxiliary examination:
[0228] Fasting insulin: 7.5 μU / mL.
[0229] diagnosis:
[0230] TCM diagnosis (TCM syndrome): obesity (phlegm-dampness syndrome);
[0231] Western medicine diagnosis: insulin resistance
[0232] Treatment advice:
[0233] 12 packs: 12g of dried tangerine peel, 12g of aconite root, 30g of Poria, 10g of licorice slices, 30g of lotus leaves, 10g of Alisma orientalis, 30g of wax gourd peel, 10g of duckweed, 10g of turmeric, 30g of astragalus, 12g of red yeast rice, 15g of cimicifuga, 30g of clean hawthorn, and 30g of pumice, decocted first.
[0234] One dose / day, divided into two doses / day, 200ml each time.
[0235] Treatment Effect:
[0236] After taking the medicine, compared with the initial diagnosis, the patient's TCM symptoms improved, weight decreased, and fasting serum insulin decreased significantly.
Claims
1. A Chinese medicine composition, which is made from the following Chinese medicines in parts by weight: The main drug is 60-110 parts of processed aconite root; The ministerial drugs include 180-230 parts of Astragalus and 80-130 parts of Poria; The adjuvants include 60-110 parts of dried tangerine peel, 60-110 parts of red yeast rice, 180-230 parts of wax gourd peel, 40-90 parts of oriental rhizome, 40-90 parts of lotus leaf, 40-90 parts of duckweed, 40-90 parts of turmeric, 180-230 parts of raw hawthorn, 180-230 parts of gynostemma pentaphyllum, 60-110 parts of northern bupleurum, 40-90 parts of stir-fried mustard seeds and 60-110 parts of cimicifuga; The adjuvant is 40-90 portions of liquorice tablets.
2. The Chinese medicine composition according to claim 1, characterized in that: The Chinese medicine composition is made of the following Chinese medicines in parts by weight: The main drug is 70-100 parts of processed aconite root; The ministerial drugs include 190-220 parts of Astragalus and 90-120 parts of Poria; The adjuvants include 70-100 parts of dried tangerine peel, 70-100 parts of red yeast rice, 190-220 parts of wax gourd peel, 50-80 parts of oriental rhizome, 50-80 parts of lotus leaf, 50-80 parts of duckweed, 50-80 parts of turmeric, 190-220 parts of raw hawthorn, 190-220 parts of gynostemma pentaphyllum, 70-100 parts of northern bupleurum, 50-80 parts of stir-fried mustard seeds and 70-100 parts of cimicifuga; The drug is 50-80 portions of licorice tablets.
3. The Chinese medicine composition according to any one of claims 1 or 2, characterized in that: The Chinese medicine composition is made of the following Chinese medicines in parts by weight: The main drug is 80-90 parts of processed aconite root; The ministerial drugs include 200-210 parts of Astragalus and 100-110 parts of Poria; The adjuvants include 80-90 parts of dried tangerine peel, 80-90 parts of red yeast rice, 200-210 parts of wax gourd peel, 60-70 parts of oriental rhizome, 60-70 parts of lotus leaf, 60-70 parts of duckweed, 60-70 parts of turmeric, 200-210 parts of raw hawthorn, 200-210 parts of gynostemma pentaphyllum, 80-90 parts of northern bupleurum, 60-70 parts of stir-fried mustard seeds and 80-90 parts of cimicifuga; The adjuvant is 60-70 portions of licorice tablets.
4. A Chinese medicine preparation, which is made from the Chinese medicine composition according to any one of claims 1 to 3.
5. The Chinese medicine preparation as claimed in claim 4, further comprising pharmaceutically acceptable excipients required for the corresponding preparation.
6. The Chinese medicine preparation according to any one of claims 4 or 5, wherein the Chinese medicine preparation is one or more of a paste, pills, elixirs, decoctions, granules, capsules, powders and / or tablets; preferably, the Chinese medicine preparation is a pill.
7. A method for preparing a Chinese medicine preparation, which comprises, by weight, 60-110 parts of processed aconite, 180-230 parts of astragalus, 80-130 parts of tuckahoe, 60-110 parts of dried tangerine peel, 60-110 parts of red yeast rice, 180-230 parts of wax gourd peel, 40-90 parts of oriental alisma, 40-90 parts of lotus leaf, 40-90 parts of duckweed, 40-90 parts of turmeric, 180-230 parts of raw hawthorn, 180-230 parts of gynostemma pentaphyllum, 60-110 parts of northern bupleurum, 40-90 parts of stir-fried mustard seeds, 60-110 parts of cimicifuga and 40-90 parts of liquorice tablets, and the preparation steps are as follows: S1. Preparation of Chinese medicine powder: Mix and grind raw hawthorn, Gynostemma pentaphyllum, tangerine peel, red yeast rice, oriental rhizome, turmeric, Poria cocos, northern bupleurum, and cimicifuga into fine powder; S2. Preparation of Chinese medicine thick paste: boil wax gourd peel, lotus leaf, duckweed, processed aconite, astragalus, fried mustard, licorice tablets, filter, combine the filtrate, dry, and concentrate into a thick paste; S3. The fine powder of traditional Chinese medicine prepared in S1 is mixed with the thick paste of traditional Chinese medicine prepared in S2 to make a soft material; S4. The soft material prepared in S3 is placed in a pill making machine to be made into pellets of prescribed requirements, thereby obtaining the pills of the Chinese medicine preparation of the present invention.
8. The preparation method according to claim 7, wherein in step S2, the number of decoctions is 1-3 times; the amount of water added is 9 to 11 times the weight of the medicinal materials; the decoction time for each time is 0.5 to 1.5 hours; and the drying method is reduced pressure concentration.
9. The preparation method according to any one of claims 7 or 8, wherein in step S2, the decoction is performed twice; the amount of water added is 10 times the weight of the medicinal materials for the first time, and 9 times the weight of the medicinal materials for the second time; the decoction time for each time is 1.5 hours for the first decoction and 0.5 hours for the second decoction; the vacuum degree in the reduced pressure concentration is -0.06 to -0.12, and the concentration temperature is 55 to 65°C.
10. Use of the Chinese medicine composition according to claim 1 or the Chinese medicine preparation according to claim 2 in preparing a drug for treating obesity; the obesity includes simple obesity and metabolic obesity.
Citation Information
Patent Citations
Traditional Chinese medicine composition for treating simple obesity and traditional Chinese medicine preparation thereof
CN108272924A
Weight-losing traditional Chinese medicine composition and preparation method thereof
CN112691179A
Preparation process of blood glucose reducing tea
CN113398208A
Traditional Chinese medicine composition for treating damp-heat type obesity
CN114191513A
Weight-reducing Chinese medicinal formulation and preparation process thereof
CN1768815A
